Stock listing
QTRX Stock Price, News, Filings & Events — Quanterix Corporation
Selected listing: QTRX · NASDAQ · USD · US
This page tracks Quanterix Corporation's QTRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following QTRX:NASDAQ. QTRX:NASDAQ is the stock-level entry point for investors researching Quanterix Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Quanterix Corporation, trading under the ticker QTRX, is a public company based in the United States with a market capitalization of approximately $182 million. The company specializes in advanced diagnostic technologies that enhance the detection and measurement of biomarkers. Quanterix aims to improve healthcare outcomes through its innovative solutions in precision medicine.
- Ticker
- QTRX:NASDAQ
- Asset type
- Stock
- Market cap
- $163.9M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Quanterix Corporation QTRX:NASDAQ stock context
This page tracks Quanterix Corporation's QTRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following QTRX:NASDAQ. QTRX:NASDAQ is the stock-level entry point for investors researching Quanterix Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Quanterix Corporation, trading under the ticker QTRX, is a public company based in the United States with a market capitalization of approximately $182 million. The company specializes in advanced diagnostic technologies that enhance the detection and measurement of biomarkers. Quanterix aims to improve healthcare outcomes through its innovative solutions in precision medicine.
Latest news from Quanterix Corporation
Quanterix Names Jim Gute Chief Commercial Officer
August 10, 2026
Quanterix Releases Financial Results for the Second Quarter of 2026
August 10, 2026
Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026
August 4, 2026
Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2026
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Mult...
July 14, 2026
Quanterix Corporation earnings calls
Quanterix Corporation (QTRX) Q2 2026 Earnings Call
August 10, 2026 · Replay with transcript and chapters
Quanterix Corporation (QTRX) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Quanterix Corporation (QTRX) Q3 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Quanterix Corporation (QTRX) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Quanterix Corporation (QTRX) Q1 2025 Earnings Call
May 12, 2025 · Replay with transcript and chapters
Quanterix Corporation (QTRX) Q4 2024 Earnings Call
March 17, 2025 · Replay with transcript and chapters
Research Quanterix Corporation
Quanterix Corporation investor report
Review AI stock analysis and investor report context for QTRX:NASDAQ.
Quanterix Corporation company profile
View the public company page for Quanterix Corporation on 6ix.
Quanterix Corporation news
Read company news and market updates connected to Quanterix Corporation.
Quanterix Corporation investor events
Find investor webinars, events, and replay context for Quanterix Corporation.